Skip header and navigation

3 records – page 1 of 1.

Choix d’accouchement après une césarienne

https://libcat.nshealth.ca/en/permalink/chpams36446
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1891
Available Online
View Pamphlet
La présente brochure explique les choix offerts aux femmes qui ont eu un bébé par césarienne (parfois appelée naissance par césarienne ou opération césarienne). Les femmes qui ont eu une césarienne ont souvent un accouchement vaginal à leur prochaine grossesse. On peut alors parler d’épreuve du travail après césarienne ou d’accouchement vaginal après césarienne (AVAC). La présente brochure explique si vous pouvez planifier un AVAC et traite de ce qui favorise la sécurité et la réussite d’un AVA…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Vaginal Birth after Cesarean
Subjects (LCSH)
Childbirth
Abstract
La présente brochure explique les choix offerts aux femmes qui ont eu un bébé par césarienne (parfois appelée naissance par césarienne ou opération césarienne). Les femmes qui ont eu une césarienne ont souvent un accouchement vaginal à leur prochaine grossesse. On peut alors parler d’épreuve du travail après césarienne ou d’accouchement vaginal après césarienne (AVAC). La présente brochure explique si vous pouvez planifier un AVAC et traite de ce qui favorise la sécurité et la réussite d’un AVAC, ainsi que des avantages et risques de l’AVAC.
This is a French translation of the English pamphlet 1847, “Options for Birth after Cesarean”. This pamphlet explains the options available to women who have had a baby by cesarean birth (sometimes called “cesarean delivery”, “c-section” or “CS”). Women who have had a cesarean often give birth vaginally in their next pregnancy. This may be referred to as Trial of Labour after Cesarean (TOLAC) or Vaginal Birth after Cesarean (VBAC). When you can plan for a VBAC, what makes a VBAC safe and successful, as well as the benefits and risks of VBAC, are listed.
Responsibility
Adapted by: Reproductive Care Program of Nova Scotia from PL-0902 with permission of IWK Perinatal Centre, Halifax NS © 2015
Pamphlet Number
1891
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35880
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1816
Available Online
View Pamphlet
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 est utilisée pour assouplir le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé. ; This pamphlet is a French translation of "Induction of Labour and Cer…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynaecology
Abstract
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 est utilisée pour assouplir le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Oral Misoprostol (Prostaglandin E1) (Cytotec®)" pamphlet 1771. Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 is used to soften the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol and when you should notify a member of your health care team.
Responsibility
Prepared by: Reproductive Care Program of Nova Scotia
Pamphlet Number
1816
Less detail

Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35821
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1771
Available Online
View Pamphlet
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 is used to soften the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au m…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia
Alternate Title
Induction of labor and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynaecology
Abstract
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 is used to soften the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec®)", is also available.
Responsibility
Prepared by: Reproductive Care Program of Nova Scotia
Pamphlet Number
1771
Less detail